Background-In patients with aortic stenosis, pressure overload induces cardiac hypertrophy and fibrosis. Female sex and estrogens influence cardiac remodeling and fibrosis in animal models and in men. Sex differences and their molecular mechanisms in hypertrophy regression after aortic valve replacement have not yet been studied. Methods and Results-We prospectively obtained preoperative and early postoperative echocardiography in 92 patients, 53 women and 39 men, undergoing aortic valve replacement for isolated aortic stenosis. We analyzed in a subgroup of 10 patients matrix gene expression in left ventricular (LV) biopsies. In addition, we determined the effect of 17␤-estradiol on collagen synthesis in isolated rat cardiac fibroblasts. Preoperatively, women and men had similar ejection fraction. Similar percentages of women and men had increased LV diameters (37% and 38%). Women more frequently exhibited LV hypertrophy than men (women: 86%; men: 56%; PϽ0.01). Postoperatively, increased LV diameters persisted in 34% of men but only in 12% of women (PϽ0.023). LV hypertrophy reversed more frequently in women than in men, leading to a similar prevalence of LV hypertrophy after surgery (women: 45%; men: 36%). In surgical biopsies, men had significantly higher collagen I and III and matrix metalloproteinase 2 gene expression than women. In isolated rat cardiac fibroblasts, 17␤-estradiol significantly increased collagen I and III gene expressions in male cells but decreased it in female cells. 
S
tenosis of the aortic valve is one of the frequent valvular diseases. More than 12 000 patients annually undergo aortic valve replacement (AVR) in Germany. At least 70% of them are aged Ն60 years; 52% are men and 48% are women.
Cardiac hypertrophy in elderly patients develops differently in women and men. [1] [2] [3] In general, women develop a more concentric form of left ventricular (LV) hypertrophy (LVH) than men with smaller ventricular diameters and less ventricular dilatation. 1 In some, but not all studies, women are characterized by higher transvalvular gradients, greater relative wall thickness, and a better systolic function. 2 In most studies, the LV mass (LVM) related to body surface area (BSA) was similar in both sexes. However, if the LVM was expressed in percentage of sex-specific normal values, derived from large population-based cohorts, women have a greater prevalence of LVH than men. 2 Cardiac hypertrophy in patients with aortic stenosis (AS) is associated with an increase in interstitial fibrosis, which is more pronounced in male hearts. 3 Our previous investigations showed an increased collagen I and III, as well as matrix metalloproteinase (MMP) expression, in predominantly male patients undergoing aortic valve surgery. 4, 5 Additional studies in rodent models revealed a significantly higher upregulation of profibrotic genes and fibrosis in male compared with female hearts after transverse aortic constriction. 6, 7 Previous studies 8, 9 suggest that estrogens inhibit collagen synthesis, but the mechanisms are not clarified so far. 10 Relief of mechanical obstruction by AVR leads to hemodynamic improvement and a substantial decrease of LVM. 11 Regression of LVM occurs early after AVR and continues up to 10 years after surgery. The late follow-up period has been studied in detail, but very few studies analyzed the early time course of regression. 12, 13 In addition, sex differences in the regression of myocardial hypertrophy and fibrosis after AVR have not yet been analyzed. This is astonishing, because sex differences in the manifestation of LVH before surgery are well accepted. Higher collagen content in males could be responsible for slower regression of LVH. Linking sex differences in regression to the molecular signature of LVH may improve our understanding on the relevance of molecular changes at the time of surgery and may point to new interventions.
This study was undertaken to compare LVH and its postoperative regression in women and men undergoing AVR for isolated AS. In a second step we analyzed myocardial biopsies to assess differences in molecular adaptation to myocardial hypertrophy in both sexes that could explain differences in regression of LVH. Because we obtained evidence of sex-specific regulation of fibrosis-related genes, we analyzed in a third step regarding whether estrogens affect collagen expression differently in fibroblasts from male and female rats.
Methods
In this prospective clinical study, 102 eligible consecutive patients, hospitalized in the main location of the Deutsche Herzzentrum Berlin for AVR because of severe isolated AS, were contacted from January 2007 to December 2008, and 92 of them were included. Inclusion criteria were informed consent and availability of echocardiography. Exclusion criteria were emergency surgery, second AVR, transapical AVR, significant coronary artery obstruction (previous or simultaneous coronary artery bypass graft or percutaneous coronary intervention), valvular heart disease (significant, ie, stage II concomitant valve disease), significant congenital heart disease, uncontrolled hypertension (blood pressure: Ͼ160/Ͼ100 mm Hg), or other noteworthy comorbidities (pre-existing cardiomyopathy or myocarditis, pacemaker, endocarditis, or malignancies) or language problems that might affect the clinical outcome or limit informed consent. The data were collected in a prospective manner. Written informed consent was obtained from all of the patients, and the study was approved by the ethical committee of Charité Universitätsmedizin Berlin.
The echocardiographic measurements were done Ϸ1 week before AVR and before discharge (3Ϯ1 day after AVR) according to recommendations of the American Society of Echocardiography. Fractional shortening and ejection fraction were calculated from the M-mode data. Structure and function of the aortic valve were analyzed as suggested in the American Society of Echocardiography guidelines.
For LV dimensions, wall thicknesses, and atrial sizes, the echocardiographically measured values were matched with predicted normal values. The predicted normal values were calculated based on sex, age, and BSA. 14 When patient's values fell within the predicted range or below they were considered "normal/low," whereas values above these reference ranges were considered "increased."
LVM was calculated by the American Society of Echocardiography cube method and related to BSA. The criteria for diagnosis of LVH were adapted as upper limits of the normal range from a large population-based study similar in their ethnicity to our cohort (women: 104 g/m 2 versus men: 125 g/m 2 ; MONICA [monitoring trends and determinants in cardiovascular disease] Augsburg). 15 In case of significant hypertrophy of the LV septum, a part of the hypertrophied septum was surgically resected and frozen immediately in liquid nitrogen. Biopsies from 10 patients were used for the molecular measurements. Data were compared with 12 LV septum biopsies from normal donor hearts that could not be used for transplantation because of age or logistic problems with the recipients.
The effect of 17␤-estradiol (E2) on mRNA expression on matrixassociated genes was measured in isolated cardiac fibroblasts from adult female and male Wistar rats (9 to 11 weeks). Cells were prepared, cultured, and treated with 10 Ϫ8 M E2 (Sigma) or Dextrin (Sigma) as vehicle as described earlier. 16 mRNA isolated from human biopsies or cardiac fibroblasts was quantified by real-time PCR as described. 4, 5 We measured mRNA content for collagen I and III and matrix metalloproteinase (MMP) 2 and 9 in relation to the expression of the genes pyruvic dehydrogenase or hypoxanthinphosphoribosyl-transferase, respectively.
Statistics were performed using SPSS version 15.0. All of the data are presented as meanϮSD. Comparisons were based on the Student t test for grouped data. Frequency distribution of men versus women was assessed using 2 analysis or Fisher exact test. Prepost changes of the LV diameters were inspected by means of the McNemar test. Significance of difference was assumed at level PϽ0.05. A repeatedmeasures logistic regression was used to model the sex dependence and temporal dependence of hypertrophy regression. A sequential multiple regression analysis 17 was applied to examine the relationship between sex and postoperative LVM indexed to BMI (LVMI) after multivariate adjustment.
Results
The study population was composed of 53 women (58%) and 39 men (42%; Table 1 ). Women were older and had lower renal function and more frequently dyspnea at rest. Thyroid disorders were more frequent in women (women: 34% versus men: 8%; PϽ0.003). Overweight, diabetes mellitus, hypertension, dyslipidemia, and atrial fibrillation had comparable prevalences in both sexes. LV ejection fraction and transvalvular and transprosthesis gradients were similar in both sexes (Table 2 ). Based on age-, sex-, and BSA-predicted values, similar percentages of women and men had increased LV dimensions at end diastole and end systole before AVR (Table 2 ). Early after valve replacement, the end-diastolic 
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Circulation September 14, 2010 dimensions decreased in both sexes. Notably, the decrease was more pronounced in women than in men (end-diastolic dimensions decrease, pre-AVR-Ͼpost-AVR, women: 5 mm versus men: 2 mm; PϽ0.041). A similar trend was found toward a greater decrease in end-systolic LV dimensions in women. Preoperatively, absolute LVM was smaller in women, and LVM related to BSA, as expected, was similar in both sexes. Based on comparison with sex-specific normal values from the MONICA Study, 15 women more frequently had LVH than men (Table 2) . After AVR, absolute LVM was significantly lower in women, and the prevalence of hypertrophy fell to a greater extent in women than in men (women: 86%-Ͼ45%, PϽ0.0001; men: 56%-Ͼ36%, PϽ0.094; Figure 1 ). This led to an equal prevalence of myocardial hypertrophy in both sexes after AVR. Thus, women more frequently had LVH before AVR but exhibit a more pronounced regression of LVM early after surgery. To confirm sex difference in the prepost changes, we used longitudinal analysis (Table S1 , available in the online Data Supplement at http://circ.ahajournals.org). Indeed, post-AVR time point (PϽ0.028) and sex (PϽ0.038) were independent predictors of hypertrophy regression. Still, after multivariate adjustment, female sex was an independent predictor of lower postoperative LVMI. Hypertension also had a significant impact on the postoperative LVMI. Thyroid disorders predicted lower LVMI with borderline significance if sex was not included in the multivariate model (PϽ0.1). After inclusion of sex (which is statistically associated with thyroid disorders) in the model, the predictive value of thyroid disorders disappeared, and only sex remained as an independent predictor for lower postoperative LVMI (Table 3) .
Men with AS had higher collagen I and III and MMP-2 and -9 gene expression in the intraoperatively obtained tissue samples than in women (Figure 2A) . Men also exhibited a significant increase in collagen I and III and MMP-2 genes in comparison with controls, but women did not. This indicates that matrix synthesis and turnover are differently regulated in women and men, with a more pronounced increase in men. The mRNA expression levels of collagen I and III were correlated with the degree of hypertrophy and changes in LV geometry in the whole group and in men ( Figure 2B ). In contrast, mRNA of metabolic genes related to glucose and fatty acid metabolism, as well as oxidative phosphorylation, were upregulated in both sexes but did not exhibit any differences between women and men (Table S2) . LVEDD, LV end-diastolic diameter; LVESD, LV end-systolic diameter; PWTd, posterior wall thickness at end diastole; IVSd, interventricular septum thickness at end diastole; RWT, relative wall thickness; dP mean, mean pressure gradient; dP peak, peak pressure gradient; FS, fractional shortening; LVEF, LV ejection fraction. Data are meanϮSD. Figure 1 . LVM was related to BSA, and patient data were compared with normal values from the MONICA cohort, Augsburg. 15 The prevalence of LVH was calculated in relation to this cohort. P values are given for the comparison between women and men and differences between pre/post-AVR.
To assess whether matrix regulation in cardiac fibroblasts may differ in women and men, that is, male and female cells, we conducted in vitro studies in rat cardiac fibroblasts from both sexes. Treatment of cardiac fibroblasts with E2 for 24 hours increased collagen I and III mRNA-expression in cells obtained from male rats compared with vehicle-treated cells ( Figure 3A ). In contrast, there was a downregulation of collagen I and III mRNA levels in cardiac fibroblasts isolated from female rats ( Figure 3B ).
Discussion
In this prospective study, we analyzed the extent and reversibility of myocardial hypertrophy in patients with isolated AS. We show for the first time that women exhibit faster regression of LVH in the early postoperative course after AVR compared with men. We identified a dysregulation of extracellular matrix turnover as a potential molecular mechanism to partially explain these sex differences in LV adaption and remodeling.
The patients in our study are mainly elderly, reflecting the present epidemiological situation in aortic valve disease. This does not preclude significant sex differences at the molecular and cellular levels. Our previous studies in mouse models already showed that sex differences in the myocardial mRNA expression and protein pattern increase with age. 18 Sex hormone exposition in earlier life probably determines reaction patterns of cells in older age. In addition, the genomic basis of a cell, that is, the presence of X and Y chromosome, determines sex-specific gene expression.
Analyzing cardiac adaption before and after AVR, we first confirmed previously reported differences in LV size between women and men. 1 To assess the prevalence of LVH in our cohort, we related the patient LVM to age-and sexcorrected normal values for LVM from an epidemiological cohort, as proposed by Dewey et al. 19 We used normal values from the MONICA cohort, Augsburg, which, as a German cohort, has ethnic similarity to our patients. 15 This confirmed that women have a greater prevalence of LVH before AVR A multiple regression analysis 17 was applied to examine the relationship between sex and postoperative LVMI after adjustment for differences in transvalvular and transprosthesis pressure gradients, body mass index (BMI), hypertension, effective orifice area (postoperative and indexed), and thyroid disorders. Using the postoperative LVMI as outcome variable, independent variables were entered in 3 blocks: (1) transvalvular and transprosthetic pressure gradients, BMI, hypertension, and effective orifice area; (2) thyroid disorders; and (3) sex. Only hypertension and sex remained as independent predictors of postoperative LVMI. 
S26
Circulation September 14, 2010 than men. Although women had a trend toward a more concentric form of LVH, female hearts in our study exhibited a relatively lower degree of concentric LVH in comparison with some previous analyses. 1,2 Notably, women in our study had a relatively high prevalence of thyroid disease, which has been endemic in our referral regions. Thyroid hormone is known to stimulate myocardial growth, and reduced thyroid hormone levels may impair the development of myocardial hypertrophy. Thus, thyroid disease may have impaired growth of the LV. Next, we analyzed molecular mechanisms that could contribute to sex-specific adaptation. Cardiac fibrosis was selected as a prime candidate because it is regulated in a sex-specific manner in mice with aortic constriction and plays a major role in LV remodeling in humans. 6 Sex differences in histologically determined collagen architecture have already been reported in human AS, but molecular analyses are lacking. 3 Our own group already showed that MMP-2 is increased and MMP-9 is decreased predominantly in male patients with AS. 4, 5 We now show for the first time that women and men differ in their matrix-related gene expression. In men, but not in women, an increase in collagen I, collagen III, and MMP-2 gene expression was observed. The data suggest significant differences in pathophysiological mechanisms related to cardiac fibrosis in women and men. Our findings in the elderly patients agree with an autopsy study, showing more fibrosis in the aging human male than in the female heart. 20 We speculate that elderly women with AS develop a different form of hypertrophy than elderly men, characterized by less fibrosis in the heart.
To support our hypotheses on sex-specific regulation of collagen synthesis, we demonstrate that E2 downregulated collagen I and III gene expressions in female but not in male rat cardiac fibroblasts. Previous in vitro studies showed that E2 suppresses rat cardiac fibroblast proliferation along with total collagen protein synthesis but did not analyze underlying regulatory mechanisms. 8 The data from our study not only show for the first time a direct and opposite regulation of collagen I and III mRNA expression by E2 in cardiac fibroblasts but also support the idea that the interaction of female sex and estrogen may prevent the upregulation of collagen in female pressure-overloaded human hearts. The observed sex differences could have multiple reasons, such as different expression levels of estrogen receptors, different estrogen receptor isoforms, different estrogen receptor phosphorylation status, or different cofactor recruitment in cells from males and females, which are certainly the focus of our further exploration.
A number of studies investigated the regression of loadinduced hypertrophy in rodent models. [21] [22] [23] The study from Yang et al 23 showed a significant reduction of 13% in LVM at day 1 after debanding and subsequent further reduction in LVM, but only in male mice. They identified a typical gene expression profile that was responsible for the fast regression. Two clinical studies investigated LVM regression after AVR. 12, 13 Christakis et al 12 found a significant decrease in LVM of Ϸ14% in Ͻ5 days after surgery, which is very similar to our own investigation. However, they did not differentiate between sexes. Djavidani et al 13 showed after AVR a 13% decrease in LVM in the early postoperative period and a further 16% in the late postoperative period. Because only 1 female patient was included in this study, they also did not differentiate between women and men. These findings, in mice and humans, are in agreement with our data and suggest that several mechanisms contribute to ventricular remodeling early and late after AVR. We speculate that ventricular unloading and fast changes in protein synthesis contribute to fast regression, predominantly in women. More cardiac fibrosis may delay the regression of LVH in men.
In conclusion, we show for the first time that regression of LVH after AVR is different in women and men, and we identified molecular mechanisms that may contribute to sex differences. New pathways may follow and may lead to more specific strategies to control remodeling in the hearts of women and men.
